Luis
Pérez de Llano
Hospital Universitario La Paz
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario La Paz (14)
2024
-
Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients
Allergy: European Journal of Allergy and Clinical Immunology
2023
-
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology
-
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13
-
Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults
Journal of Investigational Allergology and Clinical Immunology
2021
-
Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score
Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2725-2731
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
2018
2017
-
Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)
Archivos de Bronconeumologia, Vol. 53, Núm. 8, pp. 443-449
2016
-
GEMA 4.0 Spanish guidelines of the management of Asthma
Journal of Investigational Allergology and Clinical Immunology
2012
-
Involvement of Spanish Pulmonology Centers in Patient Care, Postgraduate Education and Research in Asthma: The Results of the ATENEA Survey
Archivos de Bronconeumologia, Vol. 48, Núm. 4, pp. 114-119